Takeda Pharmaceutical Company Limited Defined Benefit Obligation At Present Value
Takeda Pharmaceutical Company Limited (TKPHF) had Defined Benefit Obligation At Present Value of JPY 384.49 billion as of 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes
ifrs-full:DefinedBenefitObligationAtPresentValue · last filed 2025-06-25
- 2025-03-31: Defined Benefit Obligation At Present Value 384.49B JPY.
- 2024-03-31: Defined Benefit Obligation At Present Value 444.79B JPY.
- 2023-03-31: Defined Benefit Obligation At Present Value 401.10B JPY.
- 2022-03-31: Defined Benefit Obligation At Present Value 422.91B JPY.
| Period end | Defined Benefit Obligation At Present Value |
|---|---|
| 2025-03-31 | 384.49B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 444.79B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 401.10B JPY 20-F · filed 2024-06-26 |
| 2022-03-31 | 422.91B JPY 20-F · filed 2023-06-28 |
| 2021-03-31 | 432.09B JPY 20-F · filed 2022-06-29 |
| 2020-03-31 | 416.95B JPY 20-F · filed 2021-06-29 |
| 2019-03-31 | 426.27B JPY 20-F · filed 2020-06-24 |
| 2018-03-31 | 297.86B JPY 20-F · filed 2019-06-27 |